Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection clinical trial (NCT03266653). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of using EBV specific CTLs?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection clinical trial (NCT03266653). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to the antiviral therapies I have already tried?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection clinical trial (NCT03266653). Contact the study team or your healthcare provider for specific answers.

Question 4

What is the process for finding a suitable donor for the CTLs?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection clinical trial (NCT03266653). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection clinical trial (NCT03266653). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I expect during the treatment and recovery process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection clinical trial (NCT03266653). Contact the study team or your healthcare provider for specific answers.

What this study is about